Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOralStandard

PREMPRO/PREMPHASE

CONJUGATED ESTROGENS/MEDROXYPROGESTERONE ACETATE

Standard Dose
0.45MG/1.5MG & 0.3MG/1.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview PREMPRO/PREMPHASE is listed in Drugs@FDA under application 021396 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient CONJUGATED ESTROGENS/MEDROXYPROGESTERONE ACETATE Form and strength Tablet; Oral - 0.45MG/1.5MG & 0.3MG/1.5MG Sponsor WYETH AYERST Submission history Latest submission status date: 2003-06-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview PREMPRO/PREMPHASE is listed in Drugs@FDA under application 021396 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CONJUGATED ESTROGENS/MEDROXYPROGESTERONE ACETATE Form and strength Tablet; Oral - 0.45MG/1.5MG & 0.3MG/1.5MG Sponsor WYETH AYERST Submission history Latest submission status date: 2003-06-04 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.